Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 800-038-5 | CAS number: 1071838-81-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Élevage CHARLES RIVERS, Domaine des Oncins BP 109, 69592 L’Arbresle Cedex, FRANCE
- Age at study initiation: 8 wks
- Fasting period before study: no fasting period
- Housing: Rats were housed in a restricted area reserved to rodents and they were housed in polycarbonate cages (Makrolon: type 3) containing autoclaved dust-free bedding (sawdust + chips). Cages were changed at least once a week.
- Diet (e.g. ad libitum): Specific rat food (Genestil) was dispensed ad libitum to the animals during the study in stainless troughs
- Water (e.g. ad libitum): All animals had free access to filtered tap water, contained in polycarbonate bottles supplied with stainless teats
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 24°C
- Humidity (%): 40% to 70%
- Air changes (per hr): 15 to 20 cycles/hour of filtered, non-recycled air
- Photoperiod (hrs dark / hrs light): 12h / 12h
IN-LIFE DATES: From: 2013-02-05 To: 2013-04-12 - Route of administration:
- oral: gavage
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test item was administered as a homogeneous suspension in drinking water treated by reverse osmosis. The test item was mixed under magnetic stirrer (for homogeneous suspensions) with the required quantity of vehicle. The frequency of dose formulation preparation (1 preparation for 7 days) was based on the results of the stability assay realized by CiToxLAB France (Study No 39705 AHS), stating that dose formulations containing CuGUN ranging from 2 mg/mL to 200 mg/mL are considered to be suitable for routine administration in GLP toxicological studies, for up 7 days after preparation.
Concentration of the test item was assessed in drinking water treated by reverse osmosis. This information was required by GLP to ensure the quality of the test item preparation administered to rat.
VEHICLE
- Concentration in vehicle: 3, 10 and 30 g/L of test item
- Amount of vehicle (if gavage): 10 ml/kg/day
ADMINISTRATION
The dose formulations were administered by esophageal intubation using a rigid cannula. The exact volume to administrate to each animal was calculated based on the most recently recorded body weight.
The dose formulations were stirred continuously throughout the dosing procedure and were allowed to attain room temperature prior to their administration to animals.
Control animals were received the vehicle only. - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: Females were placed with the same male until pregnancy occured or until 2 weeks have elapsed
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 of pregnancy
- After successful mating each pregnant female was caged (how): 1 female/cage
- Any other deviations from standard protocol: No - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- For each dose tested, dose preparation aliquots were taken from the middle of the flask, on the 1st, 3rd and 7th preparation. CuGUN concentration was determined by the chemical analysis laboratory in INERIS, according to the method described and validated in the rapport study DRC-12-120813-11162A “Validation of the dissolved copper analytical method"
- Duration of treatment / exposure:
- Males were dosed for 2 weeks prior to mating, during the mating period, and until the end of the study.
Females were dosed throughout the study. This included 2 weeks prior to mating, the variable time of conception (up to 14 days mating), the duration of pregnancy and 4 days after delivery, up to and including the day before scheduled death. - Frequency of treatment:
- Daily, on the morning, approximately at the same time
- Details on study schedule:
- All animals were dosed after the acclimation period, for 14 days prior to mating. Day 1 corresponds to the first day of the treatment period.
Mating began after the animals have attained full sexual maturity (10 weeks for Wistar male and female rats Crl:WI(Han)).
Dosing were continued in both sexes during the mating period.
Females were placed with the same males until pregnancy was occured or until 2 weeks have elapsed.
Each morning, the females were examined for the presence of sperm. Day 0 of pregnancy was defined as the day sperm was found.
Female showing no-evidence of copulation and males were dosed after the mating period until the end of the study and were euthanized.
Daily dosing of pregnant females were continued throughout pregnancy and until Day 3 post-partum. The day of birth (when parturition is complete) were defined as Day 0 post-partum. Dams with offspring were euthanized on Day 4 post-partum. - Remarks:
- Doses / Concentrations:
30 mg/kg/day
Basis:
actual ingested - Remarks:
- Doses / Concentrations:
100 mg/kg/day
Basis:
actual ingested
gavage - Remarks:
- Doses / Concentrations:
300 mg/kg/day
Basis:
actual ingested
gavage - No. of animals per sex per dose:
- 10 males and 10 females per dose
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Dose levels were based on the results from the OECD Guideline No 407 “4-week toxicity study by the oral route (gavage) in rats of CuGUN” realized by CiToxLAB France (study No 39682 TSR). The control group was received the vehicle only (drinking water treated by reverse osmosis).
- Rationale for animal assignment (if not random): The Study Director selected the study animals on the basis of clinical observations done during the acclimation period. The animals were distributed into study groups, based on the body weights assessed the day of selection. All individual body weights were within ± 20% of the average body weight. - Positive control:
- no positive control
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: on the day of arrival, on the day of selection, from Day 1 to termination: at least once a day, and more frequently when signs of toxicity are observed.
- Cage side observations: Pertinent behavioral changes, signs of difficult or prolonged parturition and all signs of toxicity, including mortality, were
recorded. These records included time of onset, degree and duration of toxicity signs.
DETAILED CLINICAL OBSERVATIONS: No
- Time schedule: The duration of gestation was recorded and was calculated from Day 0 of pregnancy. Each litter was examined as soon as possible after delivery to
establish the number and sex of pups, still births, live births, runts (pups that are significantly smaller than corresponding control group) and the presence of gross abnormalities.
Live pups were counted and sexed and litters weighted within 24 hours after parturition (Day 0 or Day 1 post-partum) and on Day 4 post-partum. In
addition to the observations on parent animals, any abnormal behavior was recorded.
BODY WEIGHT: Yes
- Time schedule for examinations: on the day of arrival, on the day of selection, on Day 1, before the first treatment, weekly and at termination. During pregnancy, females will be weighted on Days 0, 7, 14 and 20 and within 24 hours of parturition (Day 0 or Day 1 post-partum) and Day 4 post-partum
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean weekly diet consumption calculated as g food/week: Yes
- Time schedule: weekly, except during the mating period - Sperm parameters (parental animals):
- Parameters examined in all male parental generations:
right and left testis weight, right and left epididymis weight were recorded - Litter observations:
- PARAMETERS EXAMINED
The following parameters were examined in [F1] offspring:
complete litters resorptions, complete litters cannibalized, dams with live young born, dams with live young born at day 4 post partum, livepups per dam at birth (mean), live pups per dam at 4 day post partum (mean), sex ratio (m/f) at birth (mean), sex ratio (m/f) at 4 day post partum, litter weight at birth (mean), litter weight at 4 day post partum (mean), pup weight at birth (mean), pup weight at 4 day post partum (mean), dams with abnormal pups
GROSS EXAMINATION OF DEAD PUPS: no - Postmortem examinations (parental animals):
- SACRIFICE
Special attention were paid to the organs of the reproductive system. The number of implantation sites and the number of corpora lutea will be recorded in parental females.
Ovaries, testes, epididymis, accessory sex organs and all organs showing macroscopic lesions were collected, preserved in buffered 10% formalin or in Bouin’s fixative (testes, epididymis) and prepared for histo-pathological analysis.
GROSS NECROPSY
- Adult animals will be examined macroscopically for any abnormalities or pathological changes. This were included examination of the external
surfaces, all orifices, the cranial cavity and the external surfaces of the brain, the thoracic, abdominal and pelvic cavities with their associated organs and tissues and the neck with its associated organs and tissues.
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated in Appendix 6 of the final report were prepared for microscopic examination and weighed, respectively. - Postmortem examinations (offspring):
- SACRIFICE
- Dead pups and pups euthanized on Day 4 post-partum will be carefully examined externally for gross abnormalities. - Statistics:
- Data were manually recorded in study books prepared before the study. These data were then transferred into computer files (Excel format) and analyzed using either Excel and/or GraphPad Prism® softwares.
- Reproductive indices:
- Pairs started (n)
Vaginal sperm detected (n)
Female achieving pregnancy
Conceiving days 1-5 (n)
Conceiving days 6 and up (n)
Pregnancy = 21 days (n)
Pregnancy = 22 days (n)
Pregnancy = 23 days (n)
Complete litter resorptions
Complete litters cannibalized
Dams with live young born (n)
Dams with live young at day 4 post partum
Corpora lutea per dam (mean)
Implants per dam (mean) - Offspring viability indices:
- Complete litter resorptions
Complete litters cannibalized
Dams with live young born (n)
Dams with live young at day 4 post partum
Corpora lutea per dam (mean)
Implants per dam (mean)
Live pups per dam at birth (mean)
Live pups per dam at day 4 post partum
Sex ratio (m/f) at birth (mean)
Sex ration (m/f) at day 4 post partum (mean)
Litter weight at birth (mean)
Litter weight at day 4 post partum (mean)
Pup weight at birth (mean, g)
Pup weight at day 4 post partum (mean, g)
Dams with abnormal pups
Preimplantation loss (corpora lutea minus implantations)
Postimplantions loss (implantations minus live births)
Post-natal loss (live birth minus alive at day 4 post partum) - Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Some effects were observed:
- group 1 (control):
- group 2 (300 mg/kg) : thin hair coat (3/10), loss waight (1/10), noisy respiration (2/10), brown mouth outlines (1/10), abnormal respiration (1/10), brown stains on nose (1/10)
- group 3 (100 mg/kg) : thin hair coat (1/10), piloerection (1/10) decrease activity (1/10)
These effects were considered not relevant for NOAEL determination. - Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Male rats BW decreased for the 300 mg/kg group whereas no effect was observed for female.
These effects were considered not relevant for NOAEL determination. - Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- FC decreased for the male rats treated at 300 mg/kf of CuGUN during the first week of exposure (no effect on the 2nd, 3rd and 4th week of exposure) and for the female at 300 mg/kg during the first and third week of exposure (no effect on the 2nd and 4th week of exposure).
These effects were considered not relevant for NOAEL determination. - Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- No significantly effects
- Other effects:
- not examined
- Reproductive function: oestrous cycle:
- no effects observed
- Description (incidence and severity):
- No significantly effects
- Reproductive function: sperm measures:
- no effects observed
- Description (incidence and severity):
- No significantly effects
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- No significantly effects
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 300 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- not examined
- Histopathological findings:
- not examined
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- > 300 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- viability
- sexual maturation
- clinical signs
- mortality
- body weight and weight gain
- Reproductive effects observed:
- not specified
- Conclusions:
- Under the experimental conditions of this study, the test item, CuGUN at a dose og 300, 100 and 30 mg/kg did not cause reproductive and developmental toxicity by oral exposure. Therefore, according ti the regulation 1272/2008/EEC, the classification of the test item is "not classified" based on the reproduction/developmental toxocity screening test (OECD guideline n°421)
- Executive summary:
The objective of this study was to evaluate the reproduction and developmental toxicity of the test item Copper Guanylurea Nitrate (CuGUN), in Wistar rat. The study design was based on OECD Guideline No. 421.
This reproduction/developmental toxicity screening test is designed to generate information concerning the effects of CuGUN on male and female reproductive performance such as gonadal function, mating behavior, conception, development of the conceptus and parturition.
Method
Three doses of CuGUN were administered (300, 100 and 30 mg/kg/day bodyweight) to groups of males and females.
Males were dosed for 2 weeks prior to mating, during the mating period, and until the end of the study.
Females were dosed throughout the study. This included 2 weeks prior to mating (with the objective of covering at least two complete oestrus cycles), the variable time of conception (up to 14 days mating), the duration of pregnancy and 4 days after delivery, up to and including the day before scheduled death.
Results
Male and female WISTAR rats were treated with 300, 100 and 30 mg/kg/day of CUGUN
No unscheduled deaths, no clinical signs, no macroscopic changes and no microscopic changes considered to be related to the treatment of CuGUN were observed on parent animals and their offspring treated, during the observation period.
Conclusion
Under the experimental conditions of this study, the test item, CuGUN at a dose of 300, 100 and 30 mg/kg/day did not cause reproductive and developmental toxicity by oral exposure. Therefore, according to the regulation 1272/2008/EEC, the classification of the test item is "not classified" based on the reproduction/developmental toxicity screening test (OECD guideline N°421)
Reference
BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS): BW gain of male rats was significantly reduced in the high-dose group (300 mg/kg), food consumption in males was significantly decreased from controls in the high-dose group (300 mg/kg) in the first dosing week (0-7 day). In females, the high-dose group showed significantly decreased food consumption in the second ans fourth dosing week.
REPRODUCTIVE FUNCTION: ESTROUS CYCLE (PARENTAL ANIMALS)
REPRODUCTIVE FUNCTION: SPERM MEASURES (PARENTAL ANIMALS)
REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
ORGAN WEIGHTS (PARENTAL ANIMALS)
GROSS PATHOLOGY (PARENTAL ANIMALS)
HISTOPATHOLOGY (PARENTAL ANIMALS)
OTHER FINDINGS (PARENTAL ANIMALS)
CLINICAL SIGNS (OFFSPRING)
BODY WEIGHT (OFFSPRING)
SEXUAL MATURATION (OFFSPRING)
ORGAN WEIGHTS (OFFSPRING)
GROSS PATHOLOGY (OFFSPRING)
HISTOPATHOLOGY (OFFSPRING)
OTHER FINDINGS (OFFSPRING)
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Only one study available but quality is sufficient for no observed effect level determination.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
There were no adverse effects observed in the repeated dose toxicity study in reproductive organs of tissues or any adverse effects in the screening study for reproductive toxicity.
No data are available for other routes of exposure (inhalation and dermal route). However, as no reproductive effect was observed for oral exposure, no reproductive effect is expected by inhalation and dermal route. Indeed, the exposure by inhalation is expected to be very low based on the very low vapour pressure (0.0000009 Pa) and the particles size (only 10 % of particles are below 13.5 µM, more than 90 % of particles are non inhalable). According to the acute toxicity study results, CuGUN seem to be more toxic by oral route than dermal route. This is probably due to a more important absorption by oral route than dermal.
Short description of key information:
No unscheduled deaths, no clinical signs, no macroscopic changes and no microscopic changes considered to be related to the treatment (30, 100 and 300 mg/kg/day) were observed on parent animals and their offspring treated during the observation period. Therefore, under the experimental conditions of this reproduction/developmental toxicity screening test, the test item, CuGUN at a dose of 300, 100 and 30 mg/kg/day did not cause reproductive toxicity by oral exposure.
Justification for selection of Effect on fertility via oral route:
The study was performed in accordance to OECD 421 and to GLP. No deviation was observed.
Effects on developmental toxicity
Description of key information
No unscheduled deaths, no clinical signs, no macroscopic changes and no microscopic changes considered to be related to the treatment (30, 100 and 300 mg/kg/day) were observed on parent animals and their offspring treated during the observation period. Therefore, under the experimental conditions of this reproduction/developmental toxicity screening test, the test item, CuGUN at a dose of 300, 100 and 30 mg/kg/day did not cause developmental toxicity by oral exposure.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
There were no adverse effects observed in the screening study for developmental toxicity.
No data are available for other routes of exposure (inhalation and dermal route). However, as no developmental effect was observed following oral exposure, no developmental effect is expected by inhalation and dermal route. Indeed, the exposure by inhalation is expected to be very low based on the very low vapour pressure (0.0000009 Pa) and the particles size (only 10 % of particles are below 13.5 µM, more than 90 % of particles are non inhalable). According to the acute toxicity study results, CuGUN seems to be more toxic by oral route than dermal route. This is probably due to a more important absorption by oral route than dermal.
Justification for classification or non-classification
Under the experimental conditions of this study, the test item, CuGUN at a dose of 300, 100 and 30 mg/kg/day did not cause reproductive and developmental toxicity by oral exposure. Therefore, according to the regulation 1272/2008 (CLP), the classification of the test item is "not classified" based on the reproduction/developmental toxicity screening test (OECD guideline N°421).
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.